The company's antibody-drug conjugate and bispecific antibody pipeline includes peptide-linker components, and its oncology focus positions it strongly in the Oncology Peptide Therapy segment (11.79% CAGR through 2031)
Scientific studies have shown that Epithalon can activate telomerase an enzyme that helps maintain telomere length and supports DNA stability
The FDA has confirmed there is no legal basis for compounding pharmacies to include BPC-157 in compounded medications
Direct glutathione quantification by LC-MS/MS: comparison with HPLC with electrochemical detection
In contrast, its use in specific clinical contextssuch as circadian rhythm sleep disorders, neurodegenerative diseases, or metabolic dysregulationis addressed as an adjunctive therapeutic approach, where evidence remains heterogeneous and often limited to small-scale or short-term studies
Statements not evaluated by the FDA Products You Can Trust Four pillars to protect your health at every step